Metabolite

KNApSAcK Entry

id C00019689
Name Orotic acid / 6-Uracilcarboxylic acid
CAS RN 65-86-1
Standard InChI InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)
Standard InChI (Main Layer) InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)

Cluster

Phytochemical cluster
KCF-S cluster No. 5438

Link

ChEMBL

By standard InChI CHEMBL1235017
By standard InChI Main Layer CHEMBL1235017

KEGG

By LinkDB C00295

CTD

By CAS RN D009963

Species

Summary

Plant class

class name count

Family

family name count
Enterobacteriaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Escherichia coli 562 Enterobacteriaceae Bacteria

Human Protein / Gene in interaction

3 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P02545 Prelamin-A/C Unclassified protein CHEMBL1235017 CHEMBL1614544 (1)
11 / 10
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL1235017 CHEMBL1614458 (1)
0 / 0
P37231 Peroxisome proliferator-activated receptor gamma NR1C3 CHEMBL1235017 CHEMBL1794510 (1)
5 / 3

CTD interaction (8)

compound gene gene name gene description interaction interaction type form reference
pmid
D009963 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) Orotic Acid inhibits the reaction [STK11 protein results in decreased phosphorylation of RPS6KB1 protein] decreases phosphorylation
/ decreases reaction
protein 22863860
D009963 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) Orotic Acid results in increased phosphorylation of RPS6KB1 protein increases phosphorylation
protein 22863860
D009963 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) Sirolimus inhibits the reaction [Orotic Acid results in increased phosphorylation of RPS6KB1 protein] decreases reaction
/ increases phosphorylation
protein 22863860
D009963 57521 RPTOR
KOG1
Mip1
regulatory associated protein of MTOR, complex 1 Orotic Acid inhibits the reaction [STK11 protein results in increased phosphorylation of RPTOR protein] decreases reaction
/ increases phosphorylation
protein 22863860
D009963 57521 RPTOR
KOG1
Mip1
regulatory associated protein of MTOR, complex 1 Orotic Acid results in decreased phosphorylation of RPTOR protein decreases phosphorylation
protein 22863860
D009963 57521 RPTOR
KOG1
Mip1
regulatory associated protein of MTOR, complex 1 Sirolimus inhibits the reaction [Orotic Acid results in decreased phosphorylation of RPTOR protein] decreases phosphorylation
/ decreases reaction
protein 22863860
D009963 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) Orotic Acid inhibits the reaction [STK11 protein results in decreased phosphorylation of RPS6KB1 protein] decreases phosphorylation
/ decreases reaction
protein 22863860
D009963 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) Orotic Acid inhibits the reaction [STK11 protein results in increased phosphorylation of RPTOR protein] decreases reaction
/ increases phosphorylation
protein 22863860

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (16)

OMIM preferred title UniProt
%606641 Body mass index; bmi P37231
#115200 Cardiomyopathy, dilated, 1a; cmd1a P02545
#212112 Cardiomyopathy, dilated, with hypergonadotropic hypogonadism P02545
#609338 Carotid intimal medial thickness 1 P37231
#605588 Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 P02545
#181350 Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 P02545
#137800 Glioma susceptibility 1; glm1 P37231
#610140 Heart-hand syndrome, slovenian type P02545
#176670 Hutchinson-gilford progeria syndrome; hgps P02545
#151660 Lipodystrophy, familial partial, type 2; fpld2 P02545
#604367 Lipodystrophy, familial partial, type 3; fpld3 P37231
#248370 Mandibuloacral dysplasia with type a lipodystrophy; mada P02545
#613205 Muscular dystrophy, congenital, lmna-related P02545
#159001 Muscular dystrophy, limb-girdle, type 1b; lgmd1b P02545
#601665 Obesity P37231
#275210 Restrictive dermopathy, lethal P02545

KEGG DISEASE (12)

KEGG disease name UniProt
H00264 Charcot-Marie-Tooth disease (CMT) P02545 (related)
H00294 Dilated cardiomyopathy (DCM) P02545 (related)
H00420 Familial partial lipodystrophy (FPL) P02545 (related)
P37231 (related)
H00563 Emery-Dreifuss muscular dystrophy P02545 (related)
H00590 Congenital muscular dystrophies (CMD/MDC) P02545 (related)
H00593 Limb-girdle muscular dystrophy (LGMD) P02545 (related)
H00601 Hutchinson-Gilford progeria syndrome P02545 (related)
H00663 Restrictive dermopathy P02545 (related)
H00665 Mandibuloacral dysplasia P02545 (related)
H01216 Left ventricular noncompaction (LVNC) P02545 (related)
H00032 Thyroid cancer P37231 (related)
H00409 Type II diabetes mellitus P37231 (related)

Diseases related to CTD interactions

1 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D006949 D009963 Hyperlipidemias therapeutic
69995